U.S. market Closed. Opens in 4 hours 6 minutes

ESTA | Establishment Labs Holdings Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 37.11 - 41.99
52 Week Range 22.05 - 60.12
Beta 0.95
Implied Volatility 63.39%
IV Rank 22.43%
Day's Volume 751,609
Average Volume 423,758
Shares Outstanding 28,763,577
Market Cap 1,202,605,154
Sector Healthcare
Industry Medical - Devices
IPO Date 2018-07-19
Valuation
Profitability
Growth
Health
P/E Ratio -16.14
Forward P/E Ratio N/A
EPS -2.59
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 857
Country Costa Rica
Website ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
*Chart delayed
Analyzing fundamentals for ESTA we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see ESTA Fundamentals page.

Watching at ESTA technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ESTA Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙